Masayoshi Harigai - Concepedia

Author

Masayoshi Harigai

Also Known As

Harigai, Masayoshi, Katsunori Ikari, M HARIGAI, M Harigai, M. HARIGAI, M. Harigai, MASAYOSHI HARIGAI, Masayoshi HARIGAI, Masayoshi Harigai, Nevin Hammam

583

Publications

14.5K

Citations

H-Index

151

Concepts

All Affiliations

Tokyo Women's Medical University Tokyo Medical and Dental University Keio University University of Occupational and Environmental Health Japan Hokkaido University

About

Masayoshi Harigai is an author at Tokyo Women's Medical University specializing in medicine, autoimmune disease, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	35	78	4.2K
2	Public Health	14	14	801
3	Natural Sciences	3	3	804
4	Social Sciences	2	2	100
5	Health Sciences	1	1	19

Masayoshi Harigai

222

Publications

11.4K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) Maxime Dougados, Martin Soubrier, Anna Antunez, Annals of the Rheumatic Diseases	2013	841
Identification of a p53-dependent negative response element in the bcl-2 gene. Toshiyuki Miyashita, Masayoshi Harigai, Masahito Hanada, PubMed Cancer ResearchCell RegulationMedicineNatural SciencesBcl-2 Gene	1994	747
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis Tsutomu Takeuchi, Yoshihiko Tatsuki, Yashiro Nogami, Annals of the Rheumatic Diseases	2007	412
Mechanisms of Transcriptional Activation of bcl-2 Gene Expression by 17β-Estradiol in Breast Cancer Cells Lian Dong, Weili Wang, Fan Wang, Journal of Biological Chemistry	1999	256
Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan Takao Koike, Masayoshi Harigai, Shigeko Inokuma, The Journal of Rheumatology	2013	210
Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study Ken‐ei Sada, Masahiro Yamamura, Masayoshi Harigai, Arthritis Research & Therapy	2014	206
Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients Masayoshi Harigai, Shigeko Inokuma, Naoki Ishiguro, Annals of the Rheumatic Diseases	2011	187
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan Takao Koike, Masayoshi Harigai, Shigeko Inokuma, The Journal of Rheumatology	2009	183
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Modern Rheumatology	2013	161
Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety Yukiko Komano, Michi Tanaka, Toshihiro Nanki, The Journal of Rheumatology	2011	157

Page 1